Rejuvesol (Citra Labs LLC)


Welcome to the PulseAid listing for the Rejuvesol drug offered from Citra Labs LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Citra Labs LLC
NON-PROPRIETARY NAME: Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate
SUBSTANCE NAME: SODIUM PYRUVATE; INOSINE; ADENINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: EXTRACORPOREAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-02-26
END MARKETING DATE: 0000-00-00


Rejuvesol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRejuvesol from Citra Labs LLC
LABELER NAME: Citra Labs LLC
DEA SCHEDULE:
ACTIVE STRENGTH: .55; 1.34; .034; .73; .311(g/50mL; g/50mL; g/50mL; g/50mL; g/50mL)
START MARKETING DATE: 1997-02-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 23731-7000_39fa60ec-a741-4582-8159-7a4075a7e0ff
PRODUCT NDC: 23731-7000
APPLICATION NUMBER: BN950522

Other SODIUM PYRUVATE; INOSINE; ADENINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Citra Labs LLCRejuvesol